SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 748.63 |
| Enterprise Value ($M) | 672.72 |
| Book Value ($M) | 480.92 |
| Book Value / Share | 6.31 |
| Price / Book | 1.56 |
| NCAV ($M) | 429.58 |
| NCAV / Share | 5.63 |
| Price / NCAV | 1.74 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.41 |
| Return on Assets (ROA) | -0.67 |
| Return on Equity (ROE) | -1.23 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.26 |
| Current Ratio | 6.26 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 563.70 |
| Assets | 615.04 |
| Liabilities | 134.13 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 54.55 |
| Operating Income | -213.03 |
| Net Income | -193.57 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -172.58 |
| Cash from Investing | -257.71 |
| Cash from Financing | 485.67 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Deep Track Capital, LP | 4.24 | 0.07 | |
| 13G | Commodore Capital Lp | 5.10 | ||
| 13G/A | ARK Investment Management LLC | 0.00 | -100.00 | |
| 13G | Fmr Llc | 14.50 | ||
| 13G/A | Wasatch Advisors Inc | |||
| 13G/A | Baker Bros. Advisors Lp | 9.70 | 36.33 | |
| 13G/A | Redmile Group, LLC | 9.90 | 38.80 | |
| 13G/A | Sands Arthur T | 4.70 | 20.86 | |
| 13G | Wellington Management Group Llp | 5.41 | 199.58 | |
| 13G/A | Morgan Stanley | 2.70 | -43.27 | |
| 13G/A | BlackRock, Inc. | 10.20 | 30.11 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 207,420 | 864,113 | 24.00 | |
| 220,848 | 687,288 | 32.13 | |
| 155,572 | 857,431 | 18.14 | |
| 71,722 | 755,901 | 9.49 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NAMS – NewAmsterdam Pharma Company N.V. | NEUP – Neuphoria Therapeutics Inc. |
| NGNE – Neurogene Inc. | NTLA – Intellia Therapeutics, Inc. |
| OCS – Oculis Holding AG |
Financial data and stock pages provided by
Fintel.io